Position in ABBV
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$2,512,122
+$534,486 QoQ
Shares Held
9,983
+9.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.54%
of 13F equity value
Holder Rank
#1,782
of 4,153 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Legacy Financial Advisors, Inc. holds $18,531,940 across 8 Drug Manufacturers - General names. ABBV ranks #4 (13.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
3,438 | $4,123,640 | |
| 2 | JNJ |
Johnson & Johnson
|
15,452 | $3,924,344 | |
| 3 | MRK |
Merck & Co., Inc.
|
28,939 | $3,718,661 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
9,983 | $2,512,122 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
26,235 | $1,511,660 | |
| 6 | AMGN |
Amgen Inc
|
3,407 | $1,233,742 | |
| 7 | PFE |
Pfizer Inc
|
34,409 | $828,568 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
5,376 | $679,203 |
All Filings in ABBV
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,512,122 | 9,983 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $1,977,636 | 9,093 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $2,089,312 | 9,144 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $2,182,727 | 9,427 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $1,758,007 | 9,471 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $2,069,638 | 9,878 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $1,671,801 | 9,408 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $1,804,177 | 9,136 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,498,398 | 8,736 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $1,606,122 | 8,820 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $1,304,692 | 8,419 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $1,179,660 | 7,914 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $853,245 | 6,333 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $1,284,044 | 8,057 | Shares | Sole | 2023-05-03 | |
| 2022-12-31 | $1,168,440 | 7,230 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $747,549 | 5,570 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $738,997 | 4,825 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $869,071 | 5,361 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $539,839 | 3,987 | Shares | Sole | 2022-02-04 | |
| 2021-09-30 | $407,101 | 3,774 | Shares | Sole | 2021-10-26 | |
| 2021-06-30 | $462,387 | 4,105 | Shares | Sole | 2021-07-21 | |
| 2021-03-31 | $515,018 | 4,759 | Shares | Sole | 2021-04-28 | |
| 2020-12-31 | $492,997 | 4,601 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $366,651 | 4,186 | Shares | Sole | 2020-11-09 | |
| No filing history on record for this holder in this stock. | ||||||